rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RXST
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Stifel cuts RxSight stock price target on competitive pressures
      Nov 4Investing.comRXST
      RxSight, Inc. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceRXST
      Wells Fargo cuts RxSight stock price target on lower revenue estimates
      Nov 4Investing.comRXST
      RxSight Inc (RXST) (Q3 2026) Earnings Call Highlights: Revenue Slides 19% as Sales Force ...

      RxSight Inc (RXST) posted $24.6 million in Q3 2026 revenue amid competitive and internal disruption, while completing a restructuring and advancing its Alcon partnership and next-gen lens pipeline.

      Nov 4Yahoo FinanceRXST
      What RxSight (RXST) Said on Its Q3 Earnings Call
      Nov 4Yahoo FinanceRXST
      RxSight Q3 2026 Earnings Call Transcript
      Nov 3BenzingaRXST
      Rxsight earnings beat by $0.08, revenue fell short of estimates
      Nov 3Investing.comRXST
      RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue Estimates
      Nov 3Yahoo FinanceRXST
      RxSight, Inc. Reports Third Quarter 2026 Results
      Nov 3Yahoo FinanceRXST
      Earnings To Watch: RxSight Inc (RXST) Q3 2026 -- GF Value Sees 515% Upside

      At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

      Nov 2Yahoo FinanceRXST
      RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

      ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight’s common stock to the same employees in

      Oct 24Yahoo FinanceRXST
      RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
      Oct 20Yahoo FinanceRXST
      RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
      Oct 19Yahoo FinanceRXST
      K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
      Oct 16Yahoo FinanceRXST
      RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says

      RxSight (RXST) has upside potential if it executes salesforce expansion and utilization-growth initi

      Sep 23Yahoo FinanceRXST
      Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and Armata Pharmaceuticals (ARMP)

      Detailed price information for Rxsight Inc (RXST-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailRXSTARMP
      BofA Adjusts Price Target on RxSight to $5.50 From $6.50

      RxSight (RXST) has an average rating of hold and mean price target of $7.57, according to analysts p

      Sep 22Yahoo FinanceRXST
      RxSight at wells fargo healthcare conference: reset centers on LAL growth
      Sep 9Investing.comRXSTWFC
      RxSight CFO Mark Wilterding sells $54,044 in company stock
      Sep 3Investing.comRXST
      RxSight COO Ilya Goldshleger sells $14,205 in company stock
      Sep 3Investing.comRXST
      RxSight chief business development officer Eric Weinberg sells $14,205 in stock
      Sep 3Investing.comRXST
      RxSight CMO Ronald Kurtz sells $35,496 in shares for tax
      Sep 2Investing.comRXST
      RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference

      ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. ET in Boston, Massachusetts. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/. About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providin

      Aug 26Yahoo FinanceRXST

      This is the newest page. Registered accounts read further back.